NAVCO Pharmaceuticals Inc (TSE:NAV) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
NAVCO Pharmaceuticals Inc. has partnered with SOF Marketing on a $300,000 CAD initiative aimed at enhancing investor relations through a comprehensive online marketing strategy. The campaign, running until October 12, 2024, includes rebranding, social media marketing, and targeted AdWords advertising. NAVCO specializes in nanotechnology for developing innovative products to combat various pathogens, serving markets in human health, household products, and veterinary care.
For further insights into TSE:NAV stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue